Cargando…
Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus
Objective: Patients with diabetes mellitus are at increased risk for hepatitis B virus (HBV) infection and its complications. HBV vaccination is recommended for adults with diabetes in the United States and other countries. However, few studies have assessed safety and immunogenicity of hepatitis B...
Autores principales: | Van Der Meeren, Olivier, Peterson, James T., Dionne, Marc, Beasley, Richard, Ebeling, Peter R., Ferguson, Murdo, Nissen, Michael D., Rheault, Paul, Simpson, Richard W., De Ridder, Marc, Crasta, Priya D., Miller, Jacqueline M., Trofa, Andrew F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994745/ https://www.ncbi.nlm.nih.gov/pubmed/27123743 http://dx.doi.org/10.1080/21645515.2016.1164362 |
Ejemplares similares
-
Characterization of an age-response relationship to GSK's recombinant hepatitis B vaccine in healthy adults: An integrated analysis
por: Van Der Meeren, Olivier, et al.
Publicado: (2015) -
A retrospective pooled analysis assessing the effect of age on the immunogenicity of Havrix™ in healthy adults
por: Van Der Meeren, Olivier, et al.
Publicado: (2015) -
Lasting immune memory against hepatitis B in 12–13-year-old adolescents previously vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy
por: Behre, Ulrich, et al.
Publicado: (2016) -
Persistence of HBsAg‐specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults
por: Van Damme, Pierre, et al.
Publicado: (2019) -
1087 Immunogenicity and Safety of 3-Dose Primary Vaccination with Combined DTPa-HBV-IPV/Hib Vaccine in Canadian Aboriginal and non-Aboriginal Infants
por: Scheifele, David W., et al.
Publicado: (2014)